InvestorsHub Logo

The ELTP King

09/23/22 4:16 PM

#374023 RE: jour_trader #374007

What the HELL are you talking about?

- "On October 18, 2021, Elite Pharmaceuticals Inc. ("Elite”) renewed its License, Supply and Distribution Agreement with Lannett Company, Inc., ("Lannett”) to market Elite’s generic Dantrolene Capsules 25 mg, 50 mg, and 100 mg in the United States. Lannett will continue to be the exclusive U.S. distributor for the generic product owned by Elite. The First Renewal Term shall be from April 9, 2022 until April 8, 2024."

Lannett relationship is done by March 2023.




----------------------------------------------------------------------------------------------------------------------------------